Peter D. Meldrum
Algemeen Directeur bij Myriad GmbH
Actieve functies van Peter D. Meldrum
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Directeur/Bestuurslid | - | - |
Myriad GmbH
Myriad GmbH Medical/Nursing ServicesHealth Services Part of Myriad Genetics, Inc., Myriad GmbH is a German company that provides health care services. The company is based in Munich, Germany. The CEOs of the company are Nathan Alan Smith, Peter D. Meldrum, Raymond Francot. | Algemeen Directeur | - | - |
Loopbaan van Peter D. Meldrum
Eerdere bekende functies van Peter D. Meldrum
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MYRIAD GENETICS, INC. | Directeur/Bestuurslid | 15-10-2010 | 30-06-2015 |
Algemeen Directeur | 01-11-1991 | 30-06-2015 | |
Oprichter | 01-05-1991 | 30-06-2015 | |
President | 01-11-1991 | 30-06-2015 | |
ENDOCYTE, INC. | Directeur/Bestuurslid | 01-05-2012 | - |
Independent Dir/Board Member | 01-05-2012 | - | |
The Founders Fund, Inc.
The Founders Fund, Inc. Miscellaneous Commercial ServicesCommercial Services The Founders Fund, Inc. provides financial assistance to students. It offers scholarships and sponsoring solutions to students for them to defray the cost of attending colleges, universities, and professional programs. The company was founded in 1991 and is headquartered in Naples, FL. | President | - | - |
SINTX TECHNOLOGIES, INC. | Directeur/Bestuurslid | - | - |
Opleiding van Peter D. Meldrum
University of Utah | Masters Business Admin |
Westminster College (Utah) | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Duitsland | 2 |
Operationeel
Director/Board Member | 4 |
Chief Executive Officer | 2 |
President | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MYRIAD GENETICS, INC. | Health Technology |
SINTX TECHNOLOGIES, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
The Founders Fund, Inc.
The Founders Fund, Inc. Miscellaneous Commercial ServicesCommercial Services The Founders Fund, Inc. provides financial assistance to students. It offers scholarships and sponsoring solutions to students for them to defray the cost of attending colleges, universities, and professional programs. The company was founded in 1991 and is headquartered in Naples, FL. | Commercial Services |
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Myriad GmbH
Myriad GmbH Medical/Nursing ServicesHealth Services Part of Myriad Genetics, Inc., Myriad GmbH is a German company that provides health care services. The company is based in Munich, Germany. The CEOs of the company are Nathan Alan Smith, Peter D. Meldrum, Raymond Francot. | Health Services |
- Beurs
- Insiders
- Peter D. Meldrum
- Ervaring